ANGPTL8 and cardiac hypertrophy: Taken together, these results indicated that secreted ANGPTL8 ameliorated cardiac hypertrophy by binding to the membrane receptor PIRB (LILRB3) to suppress Akt/GSK3β activity (Supplementary Fig. S7).